Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 470,114 | 413,211 | 443,896 | 407,227 | 375,630 | 333,114 | 267,309 | 246,972 | 237,788 | 223,248 | 209,130 | 197,216 | 192,354 | 174,860 | 131,412 | 117,880 | 112,376 | 96,691 | 78,234 | 61,077 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $470,114K
= 0.00
The debt-to-assets ratio of Catalyst Pharmaceuticals Inc has consistently been 0.00 for all the quarters displayed in the table. This indicates that the company has not used debt financing to acquire assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets have been financed entirely by equity rather than debt. This can be a positive sign for investors and creditors as it reflects a strong financial position and low financial risk associated with leverage. However, it is important to note that a low debt-to-assets ratio may also limit the company's ability to take advantage of potential growth opportunities that could be funded using debt.
Peer comparison
Dec 31, 2023